View in EDS

Prognostic value of [18F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan.

Saved in:
Bibliographic Details
Title: Prognostic value of [18F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan.
Authors: Frega J; Université de Strasbourg Faculté de Médecine, 4 Rue Kirschleger, Strasbourg, 67000, France. frega.juliette@gmail.com.; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France. frega.juliette@gmail.com., Somme L; Oncology, Institut public de cancérologie Strauss Europe, Strasbourg, France., Martin T; Pharmacy, Institut public de cancérologie Strauss Europe, Strasbourg, France., Petit T; Oncology, Institut public de cancérologie Strauss Europe, Strasbourg, France., Salvadori J; Radiophysics, Institut public de cancérologie Strauss Europe, Strasbourg, France., Bund C; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France., Somme F; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jul 01. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42380496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic value of [<superscript>18</superscript>F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Frega+J%22">Frega J</searchLink>; Université de Strasbourg Faculté de Médecine, 4 Rue Kirschleger, Strasbourg, 67000, France. frega.juliette@gmail.com.; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France. frega.juliette@gmail.com.<br /><searchLink fieldCode="AU" term="%22Somme+L%22">Somme L</searchLink>; Oncology, Institut public de cancérologie Strauss Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Martin+T%22">Martin T</searchLink>; Pharmacy, Institut public de cancérologie Strauss Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Petit+T%22">Petit T</searchLink>; Oncology, Institut public de cancérologie Strauss Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Salvadori+J%22">Salvadori J</searchLink>; Radiophysics, Institut public de cancérologie Strauss Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Bund+C%22">Bund C</searchLink>; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Somme+F%22">Somme F</searchLink>; Nuclear Medicine and Molecular Imaging, Institut public de cancérologie Strauss Europe, Strasbourg, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2026 Jul 01. <i>Date of Electronic Publication: </i>2026 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42380496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00259-026-08029-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Prognostic value of [18F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Frega J
      – PersonEntity:
          Name:
            NameFull: Somme L
      – PersonEntity:
          Name:
            NameFull: Martin T
      – PersonEntity:
          Name:
            NameFull: Petit T
      – PersonEntity:
          Name:
            NameFull: Salvadori J
      – PersonEntity:
          Name:
            NameFull: Bund C
      – PersonEntity:
          Name:
            NameFull: Somme F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1619-7089
          Titles:
            – TitleFull: European journal of nuclear medicine and molecular imaging
              Type: main
ResultId 1